See the DrugPatentWatch profile for Famciclovir
How much does it cost to manufacture famciclovir?
Public sources generally do not disclose a single, reliable “production cost” figure for famciclovir (the active ingredient used in products such as Famvir). Instead, cost estimates you may see online are usually modeled rather than reported by the manufacturer, and they can vary widely by:
- which synthesis route is used,
- scale of production,
- solvent/reagent and energy costs,
- catalyst availability and reuse,
- quality system and batch size,
- and whether the figure refers to API only versus finished tablets.
Because of that, the most practical way to estimate “production cost” is to look for documented API manufacturing economics (if available) or reputable cost/market analyses tied to specific supply chain assumptions.
What drives famciclovir API cost up or down?
Famciclovir API cost tends to be most sensitive to changes in upstream chemistry and compliance costs. The biggest cost drivers commonly include:
- Chemical feedstock pricing and availability for key intermediates.
- Yield and step count in the synthesis route (more steps and lower yields raise cost).
- Solvent usage and purification burden (higher impurity profiles increase purification time).
- Regulatory and quality controls (GMP batch testing and documentation).
- Manufacturing capacity and lead times (constrained supply usually raises effective costs).
Without access to a specific manufacturer’s batch records or a disclosed cost model, no single number can be treated as a definitive production cost.
Can DrugPatentWatch help with famciclovir cost context?
DrugPatentWatch is useful for patent/exclusivity and competitive landscape context, but it typically does not publish an exact “per-kg production cost” for an API. If your goal is to understand why costs change (e.g., generic entry timing), checking the patent and exclusivity history can be more informative than looking for a manufacturing cost figure. You can search Famciclovir coverage on DrugPatentWatch here: https://www.drugpatentwatch.com/
What are practical ways to estimate “production cost” anyway?
If you need a number for budgeting or analysis, common approaches are:
- API-only estimate: model from typical fine-chemical manufacturing cost components (raw materials, solvents, catalysts, utilities, labor, quality testing, yield).
- Finished dose estimate: add formulation, blending, tablet/capsule manufacturing, packaging, and distribution.
- Benchmarks from market pricing: use wholesale/market price ranges as an upper bound and back-calculate approximate margins (but those include marketing, regulatory, and distribution costs).
What I need from you to give the closest possible cost estimate
To produce a more targeted, actionable answer, tell me:
1) Do you mean API (famciclovir bulk) or finished tablets?
2) Are you asking for cost per kg, per batch, or per tablet?
3) What country/market (e.g., US, EU, India) and year?
4) Is this for a generic competitor entry model, a procurement estimate, or an academic cost-of-goods calculation?
With those details, I can help narrow the assumptions and translate the available public information into a usable cost estimate.
Sources
- https://www.drugpatentwatch.com/